| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/19/1997 | CA2240108A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2238711A1 3-benzylaminopyrrolidines and piperidines as tachykinin receptor antagonists |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0779076A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 06/18/1997 | EP0778774A2 New use of prostaglandins |
| 06/18/1997 | EP0778733A1 A basic protein composition for killing or inhibiting microbial cells |
| 06/18/1997 | EP0778731A1 Ionene polymers containing biologically-active anions |
| 06/18/1997 | EP0662953B1 Novel vitamin d analogues |
| 06/18/1997 | CN1152337A Superoxide dismutase-4 |
| 06/18/1997 | CN1152304A Substituted benzamidines, their production and their use as medicaments |
| 06/18/1997 | CN1152303A Novel chemical compound, its preparation and use as drug |
| 06/18/1997 | CN1152302A Retinoic acid X-receptor ligands |
| 06/18/1997 | CN1151885A External-use Chinese medicine prepn for psoriasis |
| 06/18/1997 | CN1151879A Chinese medicine granule for acne |
| 06/18/1997 | CN1151867A Bee glue powder and its prodn |
| 06/18/1997 | CN1151866A External therapeutic composition for dermatitis |
| 06/18/1997 | CN1035177C Prep. of 20-methyl-substituted vitamin D-derivatives |
| 06/17/1997 | US5639902 (Cyclohexyl)alkene compounds |
| 06/17/1997 | US5639872 Human VEGF-specific oligonucleotides |
| 06/17/1997 | US5639767 Topically applying l-carnitine ester to skin |
| 06/17/1997 | US5639746 Inhibitors of metalloprotease |
| 06/17/1997 | US5639736 Reducing neovascularization by administering through the eye |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020842A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof |
| 06/12/1997 | WO1997020811A1 Vitamin d analogues |
| 06/12/1997 | WO1997020560A1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 06/12/1997 | CA2239501A1 Arctium majus compositions |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778284A2 New 7-beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0777653A1 Dihygropyridine derivatives as bradykinin antagonists |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777485A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 06/11/1997 | EP0777482A1 Combined preparation for the therapy of immune diseases |
| 06/11/1997 | EP0777471A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 06/11/1997 | EP0777458A1 Control of hair growth |
| 06/11/1997 | EP0711141B1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea |
| 06/11/1997 | EP0703913B1 Imidazoles as lipoxygenase inhibitors |
| 06/11/1997 | EP0700395B1 Indole derivatives as steroid 5-alpha-reductase inhibitors |
| 06/11/1997 | EP0662964B1 Heterocyclic amines having calmodulin antagonist properties |
| 06/11/1997 | EP0633763B1 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use |
| 06/11/1997 | CN1151320A Pus drawing-out ointment |
| 06/11/1997 | CN1151299A Pure Chinese medicinal liquid film for burn and its prodn. tech. |
| 06/10/1997 | US5637608 Photodynamic therapy |
| 06/10/1997 | US5637606 Hair grower based on allantoin or derivatives thereof |
| 06/10/1997 | US5637480 DNA molecules encoding bone morphogenetic protein-10 |
| 06/10/1997 | US5637305 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 06/10/1997 | US5637304 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use |
| 06/10/1997 | CA2040460C Drug delivery with thermoreversible gels |
| 06/10/1997 | CA2028725C Polymer mixtures useful in skin care |
| 06/05/1997 | WO1997019942A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 06/05/1997 | WO1997019673A2 Reduction of hair growth |
| 06/05/1997 | WO1997019672A1 Reduction of hair growth |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776899A1 Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/04/1997 | EP0776893A1 Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 |
| 06/04/1997 | EP0776885A1 Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses |
| 06/04/1997 | EP0776881A1 Bi-aromatic compounds comprising an adamantyl group in para-position, pharmaceutical and cosmetic compositions containing them and their utilization |
| 06/04/1997 | EP0776218A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 06/04/1997 | EP0776215A1 Device for delivery of substances and methods of use thereof |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0737211B1 Cationic biopolymers |
| 06/04/1997 | CN1151157A Metalloproteinase inhibitors |
| 06/04/1997 | CN1151154A Novel antitumor and antileukemia substanes, preparation thereof and pharmaceutical compositions containing same |
| 06/04/1997 | CN1151117A Binding of E-selectin, P-selectin or L-selectin to sialyl-Lewis(x) or sialyl-lewis(a) |
| 06/04/1997 | CN1151115A Topical compositions comprising N-acetyl-L-cysteine |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/04/1997 | CN1035055C Process for preparaing unsaturated 17-'beta' substituted 3-carboxysteroids |
| 06/03/1997 | US5635524 Cyclization; salt formation; separation; stimulant for beta-adrenergic receptors |
| 06/03/1997 | US5635516 (Thia) cycloalkyl[B]indole compounds as anti-inflammatory agents |
| 06/03/1997 | US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation |
| 06/03/1997 | US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 05/29/1997 | WO1997019111A2 Monoclonal antibodies anti-cd6 and their uses |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997019081A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/29/1997 | WO1997019080A1 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides |
| 05/29/1997 | WO1997019064A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |
| 05/29/1997 | WO1997019052A1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018799A1 Use of a tnf alpha antagonist for treating neurogenic skin redness |
| 05/29/1997 | WO1997013505A3 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/28/1997 | EP0775492A1 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in skin composition |
| 05/28/1997 | EP0775486A1 Antibacterial, antimycotic and antviral compositions based on alpha-hydroxyalkanoic acids and squalene |
| 05/28/1997 | EP0775482A2 Cosmetic compositions containing tricholine citrate |
| 05/28/1997 | EP0775478A1 Combinations of active ingredients based on partial glycerides and dialkylsubstituted acetic acids efficient against bacteria, mycoses and viruses |
| 05/28/1997 | EP0775203A1 Method of gene therapy using dna vectors without selection marker gene |
| 05/28/1997 | EP0775199A1 Superoxide dismutase-4 |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0775141A1 Phenyl xanthine derivatives |
| 05/28/1997 | EP0775103A1 Retinoic acid x-receptor ligands |
| 05/28/1997 | EP0581904B1 Method of inhibiting fibrosis |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150802A Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 05/28/1997 | CN1150601A Bacteriocin |
| 05/28/1997 | CN1150546A Hair regrowth liquid medicine |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |